Pacific Edge Ltd
NZX:PEB
Pacific Edge Ltd
NZX:PEB
Price:
0.185
NZD
-1.07%
Market Closed
Market Cap:
NZ$189.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pacific Edge Ltd
NZX:PEB
|
NZ |
|
Michael Anthony Holdings Inc
OTC:MAJJ
|
US |
|
Oue Commercial Real Estate Investment Trust
SGX:TS0U
|
SG |
|
Ingenta PLC
LSE:ING
|
UK |
|
E
|
ezCaretech Co Ltd
KOSDAQ:099750
|
KR |
|
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
|
CN |
|
S
|
Supreme Electronics Co Ltd
TWSE:8112
|
TW |
|
I
|
ING Bank Slaski SA
WSE:ING
|
PL |
|
Annehem Fastigheter AB (publ)
STO:ANNE B
|
SE |
|
K
|
Kothari Products Ltd
NSE:KOTHARIPRO
|
IN |
|
Nurol Gayrimenkul Yatirim Ortakligi AS
IST:NUGYO.E
|
TR |
|
H
|
House Foods Group Inc
TSE:2810
|
JP |
|
I
|
Investment Friends SE
WSE:IFR
|
EE |
|
Shinsegae International Inc
KRX:031430
|
KR |
|
A Plus Asset Advisor Co Ltd
KRX:244920
|
KR |
|
S
|
Suzhou Novosense Microlectronics Co Ltd
SSE:688052
|
CN |
|
O
|
Overseas Shipholding Group Inc
F:19O
|
US |
Multiples-Based Value
The
Multiples-Based Value for
Pacific Edge Ltd (PEB)
under the Base Case is
hidden
NZD.
Compared with the current market price of 0.185 NZD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PEB Multiples-Based Value
LOCKED
Multiples Across Competitors
PEB Competitors Multiples
Pacific Edge Ltd Competitors
Pacific Edge Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NZ |
|
Pacific Edge Ltd
NZX:PEB
|
191.1m NZD | 11.2 | -5.5 | -4.7 | -4.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88.1 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.3 | 28.4 | 21.3 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.5 | 17.6 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.4 | 39.8 | 43.2 | 44.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 2.9 | 32.4 | 10.9 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
